4th Principal Investigators Meeting Agenda
4th Principal Investigators Meeting
Innovative Molecular Analysis Technologies Program
June 16–18, 2003
Hilton San Diego Resort
San Diego, California
Agenda
| MONDAY – JUNE 16, 2003 | ||
| 7:30–8:15 a.m. | Registration and Breakfast | |
| 8:15 a.m. | Welcome Ed Monachino, NCI |
|
| 8:30 a.m. | Keynote 1: Trends and Perspectives
in Cancer Research Gordon Mills, M.D., Ph.D., University of Texas M.D. Anderson Cancer Center |
|
| Session 1—Generating the Knowledge Base for Cancer Research | ||
| 9:30 a.m. | Endothelial Cell Molecular
Alterations in Cancer Daniel Kenan, M.D., Ph.D., Duke University |
|
| 10:00 a.m. | BREAK | |
| 10:30 a.m. | Real-time in vivo Imaging
of Gene Expression by SMaRTTM (Spliceosome Mediated RNA Trans-splicing) Gerard McGarrity, Ph.D., Intronn, Inc. |
|
| 11:00 a.m. | Use of 2-D Gel/Mass Spectrometry
and Oligonucleotide DNA Microarrays to Study Tumor Protein Production
in vivo and in vitro Alvin Beitz, Ph.D., University of Minnesota |
|
| 11:30 a.m. | Translating a Transcriptome:
High-throughput Analysis of mRNA Translation David Morris, Ph.D., University of Washington |
|
| 12:00 noon | LUNCH | |
| Session 2—Creating Tools for Discovery | ||
| 1:00 p.m. | Intelligent Mapping of Gene
Expression Profiles Zuyi Wang, Ph.D., Catholic University of America |
|
| 1:30 p.m. | Surface Plasmon Enhanced
Microscopy; A New Technology with Optical Resolution of 10nm Dale Larson, M.S., Harvard Medical School |
|
| 2:00 p.m. | SH2 profiling: classifying
tumor cells on the basis of global tyrosine phosphorylation state
Bruce Mayer, Ph.D., University of Connecticut |
|
| 2:30 p.m. | Nucleic Acid-Based Biosensors
as Tools for Cancer Research and Drug Discovery Martin Stanton, Ph.D., Archemix Corporation |
|
| 3:00 p.m. | BREAK | |
| NCI Funding Opportunities for IMAT Technology | ||
| 3:30 p.m. | DCB (basic research tools, mouse models, etc.) Dan Gallahan, Ph.D. | |
| 3:50 p.m. | DCP (prevention, early detection, EDRN) Sudhir Srivastava, Ph.D., M.P.H. | |
| 4:10 p.m. | DTP (drug discovery/development) Ron Dubois, Ph.D. | |
| 4:30 p.m. | CDP (diagnosis, prognosis) Tracy Lugo, Ph.D. | |
| 5:00–5:30 p.m. | Review and Transition Process Dan Gallahan, Ph.D. |
|
| 5:00–9:00 p.m. | Poster Session and Interface with NCI programs | |
| TUESDAY – JUNE 17, 2003 | ||
| 7:00–8:00 a.m. | Registration Breakfast |
|
| Session 1: IP Tech Transfer | ||
| 8:00 a.m. | University Technology Transfer;
Perspectives, Policies and Practical Advice Irene Abrams, M.A., Massachusetts Institute of Technology |
|
| 8:45 a.m. | Commercialization: Entrepreneurs
in the New Landscape of Biotech Investment Allen Baker, C.Phil., Dawnbreaker |
|
|
Session 2: Moving Technology
in a Clinical Direction
|
||
| 9:30 a.m. | The Long and Winding Road:
From Research Diagnostics to Clinical Implementation Steve Piccoli, Ph.D., Fujirebio Diagnostics, Inc. |
|
| 10:15 a.m. | in vitro Diagnostics—Overview Maria Chan, Ph.D., CDRH, FDA |
|
| 11:00 a.m. | Panel Discussion: Speakers from Session 1 and 2 | |
| 12:00 noon | LUNCH | |
| 1:00 p.m. | Keynote 2: How to Move Tech
Forward Dr Steve Lee, Ph.D., Ohio State University |
|
|
Session 3: Moving New Tools
into the Lab & Clinic
|
||
| 1:30 p.m. | Functional Proteomics to
Identify Proteins in Cancer Cell Invasion Dan Jay, Ph.D., Tufts University |
|
| 2:00 p.m. | Epigenomic Changes During
Leukemia Cell Differentiation: Analysis of Histone Acetylation and
Cytosine Methylation Using CpG Island Microarrays Bernard Futscher, Ph.D., Univeristy of Arizona |
|
| 2:30 p.m. | Rapid Molecular Detection
of PML/RAR Using Electrochemical Sensorarray Vincent Gau, Ph.D., Genefluidics, Inc. |
|
| 3:00 p.m. | Vertical Coverage Arrays
in Analyzing Transcription John Welsh, Ph.D., Sidney Kimmel Cancer Center |
|
| 3:30 p.m. | BREAK | |
| 4:00 p.m. | Update on the SBIR program Jennifer Couch, Ph.D.and Anne Heath |
|
| 5:00–9:00 p.m. | Poster Session | |
| WEDNESDAY – JUNE 18, 2003 | ||
| 7:30–8:30 a.m. | Breakfast | |
| 8:30 a.m. | Keynote 3: Genomic
Analyses of Clinical Breast Cancer Suzanne Fuqua, Ph.D., Baylor College of Medicine |
|
| Session 4 —Exploring Human Cancer | ||
| 9:30 a.m. | Methylated CpG Island Amplification
for Methylation Profiling of Cancer Jean-Pierre Issa, M.D., University of Texas at M.D. Anderson Cancer Center |
|
| 10:00 a.m. | Vascular Proteomics: Mapping
Targets on Endothelia and Caveolae in vivo for Organ- and Tumor-Directed
Delivery and Transcytosis Jan Schnitzer, M.D., Sidney Kimmel Cancer Center |
|
| 10:30 a.m. | BREAK | |
| 11:00 a.m. | Assessment of Plasma DNA
levels, Allelic Imbalance and CA-125 as Diagnostic Tests for Cancer
Ie-Ming Shih, M.D., Ph.D., Johns Hopkins University |
|
| 11:30 a.m. | Gene Expression Profiling
of Unknown Primary Cancers Dr Branimir Sikic, M.D., Stanford University |
|
| 12:00 noon | Adjourn | |
Back to Top
